camilescafe.com
FDA Advisory Committee recommends US FDA approval of BRILINTA (ticagrelor) for Acute Coronary Syndromes
Abbott's SIMCOR (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths
Methodological characteristics of academic clinical drug trials - a retrospective cohort study of applications to the Danish Medicines Agency 1993-2005
Abbott Fund-Sponsored Laboratory Training Initiative Helps Stem Critical Shortage of Medical Professionals in California
Allos Therapeutics Announces Topline Results from Phase 2b Study of FOLOTYN in Patients with Advanced Non-Small Cell Lung Cancer
IBM to Market UPMC 'Smart Room' Technology
Fourth "Roche Continents" study week for 100 students
GSK Rethinks Rep Compensation
Allos Therapeutics Reports Second Quarter 2010 Financial Results
A call for better quality measures from head of The Joint Commission
Members from:
Site by
Gigapixel Creative